A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme

Biophysical Chemistry

Volumn 111, Issue 2, 2004, Pages 183-189

  Andujar Sanchez M ^a   Camara Artigas A ^a   Jara Perez V ^a  

^a UNIVERSITY OF ALMERÍA   (Spain)

Author keywords

Angiotensin I converting enzyme; Binding; Enthalpy; Inhibitors; Isothermal titration calorimetry; Stoichiometry

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; LISINOPRIL;

ARTICLE; BINDING KINETICS; CALORIMETRY; DRUG PROTEIN BINDING; ENTHALPY; ENTROPY; ENZYMATIC ASSAY; ISOTHERM; PRIORITY JOURNAL; STOICHIOMETRY; THERMODYNAMICS; TITRIMETRY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CALORIMETRY; CAPTOPRIL; ENALAPRILAT; LISINOPRIL; LUNG; PEPTIDYL-DIPEPTIDASE A; SWINE; THERMODYNAMICS;

SUS SCROFA;

EID: 4644361124     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpc.2004.05.011     Document Type: Article

References (45)

1. Skeggs L.T., Kahn J.R., Shumway N.P. Preparation and function of the hypertension converting enzyme. J. Exp. Med. 103:1956;295-299
2. Ehlers M.R., Riordan J.F. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry. 28:1989;5311-5318
3. Patchett A.A., Cordes E.H. The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme. Adv. Enzymol. Relat. Areas Mol. Biol. 57:1985;1-84
4. Ondetti M.A. From peptides to peptidases: a chronicle of drug discovery. Annu. Rev. Pharmacol. 34:1994;1-16
5. Hagaman J.R., Moyer J.S., Bachman E.S., Sibony M., Magyar P.L., Welch J.E., Smithies O., Krege J.H., O'Brien D.A. Angiotensin-converting enzyme and male fertility. Proc. Natl. Acad. Sci. U. S. A. 95:1998;2552-2557
6. Soubrier F., Alhenc-Gelas F., Hubert C., Allegrini J., John M., Tregear G., Corvol P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. U. S. A. 85:1988;9386-9390
7. Corvol P., Williams T.A. Barrett A.J., Rawlings N.D., Woessner J.F. Handbook of Proteolytic Enzymes. 1998;1066-1076 Academic Press, New York
8. Kumar R.S., Kusari J., Roy S.N., Soffer R.L., Sen G.C. Structure of testicular angiotensin-converting enzyme. A segmental mosaic enzyme. J. Biol. Chem. 264:1989;16754-16758
9. Lattion A.L., Soubrier F., Allegrini J., Hubert C., Corvol P., Alhenc-Gelas F. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett. 252:1989;99-104
10. Ehlers M.R.W., Fox E.A., Strydom D.J., Riordan J.F. The testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc. Natl. Acad. Sci. U. S. A. 86:1989;7741-7745
11. Wei L., Alhenc-Gelas F., Corvol P., Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem. 266:1991;9002-9008
12. Wei L., Clauser E., Alhenc-Gelas F., Corvol P. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J. Biol. Chem. 267(19):1992;13398-13405
13. Lenfant M., Wdzieczak-Bakala J., Guittet E., Prome J.-C., Sotty D., Frindel E. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc. Natl. Acad. Sci. U. S. A. 86:1989;779-782
14. Azizi M., Rousseau A., Ezan E., Guyene T.-T., Michelet S., Grognet J.M., Lenfant M., Corvol P., Menard J. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J. Clin. Invest. 97:1996;839-844
15. Voronov S., Zueva N., Orlov V., Urutyunyan A., Kost O. Temperature-induced selective death of the C-domain within angiotensin- converting enzyme molecule. FEBS Lett. 522:2002;77-82
16. Sturrock E.D., Danilov S.M., Riordan J.F. Limited proteolysis of human kidney angiotensin-converting enzyme and generation of catalytically active N - and C-terminal domains. Biochem. Biophys. Res. Commun. 236:1997;16-19
17. Natesh R., Schwager S.L.U., Sturrock E.D., Acharya K.R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature. 421:2003;551-554
18. Kim H.M., Shin D.R., Yoo O.J., Lee H., Lee J.O. Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril. FEBS Lett. 538:2003;65-70
19. Weber P.C., Salemme F.R. Applications of calorimetric methods to drug discovery and the study of protein interactions. Curr. Opin. Struck. Biol. 13:2003;115-121
20. Leavitt S., Freire E. Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr. Opin. Struck. Biol. 11:2001;560-566
21. Ladbury J.E. Isothermal titration calorimetry: application to structure-based drug design. Thermochim. Acta. 380:2001;209-215
22. Velazquez-Campoy A., Luque I., Freire E. The application of thermodynamic methods in drug design. Thermochim. Acta. 380:2001;217-227
23. Ortiz-Salmerón E., Barón C., García-Fuentes L. Enthalpy of captopril-angiotensin I-converting enzyme binding. FEBS Lett. 435:1998;219-224
24. Téllez-Sanz R., García-Fuentes L., Barón C. Calorimetric analysis of lisinopril binding to angiotensin I-converting enzyme. FEBS Lett. 423:1998;75-80
25. Bull H.G., Thornberry N.A., Cordes E.H. Purification of angiotensin-converting enzyme from rabbit lung and human plasma by affinity chromatography. J. Biol. Chem. 260:1985;2963-2972
26. Andújar-Sánchez M., Camara-Artigas A., Jara Perez V. Purification of angiotensin I converting enzyme from pig lung using concanavalin-A sepharose chromatography. J. Chromatogr., B, Biomed. Sci. Appl. 783:2003;247-252
27. Gill S.C., von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326
28. Holmquist B., Bünning P., Riordan J.F. A continuous spectrophotometric assay for angiotensin converting enzyme. Anal. Biochem. 95:1979;540-548
29. Wiseman T., Williston S., Brandts J.F., Lin L.-N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 179:1989;131-137
30. Kabsch W. A solution for the best rotation to relate two sets of vectors. Acta Crystallogr., A. 32:1976;922-923
31. Collaborative Computational Project, Number 4 The CCP4 suite: programs for protein crystallography. Acta Crystallogr., D Biol. Crystallogr. 50:1994;760-763
32. Murphy K.P., Freire E. Thermodynamics of structural stability and cooperative folding behavior in proteins. Adv. Protein Chem. 43:1992;313-361
33. Spolar R.S., Livingstone J.R., Record M.T. Jr. Use of liquid hydrocarbon and amide transfer data to estimate contributions to thermodynamic functions of protein folding from the removal of nonpolar and polar surface from water. Biochemistry. 31(16):1992;3947-3955
34. Binevski P.V., Sizova E.A., Pozdnev V.F., Kost O.A. Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme. FEBS Lett. 550:2003;84-88
35. Fernandez M., Liu X., Wouters M.A., Heyberger S., Husain A. Angiotensin I-converting enzyme transition state stabilization by HIS1089: evidence for a catalytic mechanism distinct from other gluzincin metalloproteinases. J. Biol. Chem. 276:2001;4998-5004
36. McEvoy G.K. Captopril. AHFS-96 Drug Information. 1996;American Society of Health-System Pharmacists, Bethesda, MD
37. Velazquez-Campoy A., Luque I., Todd M.J., Milutinovich M., Kiso Y., Freire E. Thermodynamic dissection of the binding energetics of KNI-272, a potent HIV-1 protease inhibitor. Protein Sci. 9:2000;1801-1809
38. Fernandez J.H., Hayashi M.A.F., Camargo A.C.M., Neshich G. Structural basis of the lisinopril-binding specificity in N- and C-domains of human somatic ACE. Biochem. Biophys. Res. Commun. 308:2003;219-226
39. Michaud A., Chauvet M.T., Corvol P. N-domain selectivity of angiotensin I-converting enzyme as assessed by structure-function studies of its highly selective substrate, N-acetyl-seryl-aspartyl-lysyl-proline. Biochem. Pharmacol. 57:1999;611-618
40. Guy J.L., Jackson R.M., Acharya K.R., Sturrock E.D., Hooper N.M., Turner A.J. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry. 18:2003;13185-13192
41. Velazquez-Campoy A., Todd M.J., Freire E. HIV-1 protease inhibitors: enthalpic versus entropic optimization of the binding affinity. Biochemistry. 39:2000;2201-2207
42. Luque I., Freire E. Structure-based prediction of binding affinities and molecular design of peptide ligands. Methods Enzymol. 295:1998;100-127
43. Leung D., Abbenante G., Fairlie D.P. Protease inhibitors: current status and future prospects. J. Med. Chem. 43:2000;305-341
44. Vallee B.L., Williams R.J. Metalloenzymes: the entatic nature of their active sites. Proc. Natl. Acad. Sci. U. S. A. 59(2):1968;498-505
45. Bicknell R., Holmquist B., Lee F.S., Martin M.T., Riordan J.F. Electronic spectroscopy of cobalt angiotensin converting enzyme and its inhibitor complexes. Biochemistry. 26(23):1987;7291-7297